MartÃnez-López, A.L.; Carvajal-Millan, E.; Canett-Romero, R.; Prakash, S.; Rascón-Chu, A.; López-Franco, Y.L.; Lizardi-Mendoza, J.; Micard, V.
Arabinoxylans-Based Oral Insulin Delivery System Targeting the Colon: Simulation in a Human Intestinal Microbial Ecosystem and Evaluation in Diabetic Rats. Pharmaceuticals 2022, 15, 1062.
https://doi.org/10.3390/ph15091062
AMA Style
MartÃnez-López AL, Carvajal-Millan E, Canett-Romero R, Prakash S, Rascón-Chu A, López-Franco YL, Lizardi-Mendoza J, Micard V.
Arabinoxylans-Based Oral Insulin Delivery System Targeting the Colon: Simulation in a Human Intestinal Microbial Ecosystem and Evaluation in Diabetic Rats. Pharmaceuticals. 2022; 15(9):1062.
https://doi.org/10.3390/ph15091062
Chicago/Turabian Style
MartÃnez-López, Ana L., Elizabeth Carvajal-Millan, Rafael Canett-Romero, Satya Prakash, AgustÃn Rascón-Chu, Yolanda L. López-Franco, Jaime Lizardi-Mendoza, and Valerie Micard.
2022. "Arabinoxylans-Based Oral Insulin Delivery System Targeting the Colon: Simulation in a Human Intestinal Microbial Ecosystem and Evaluation in Diabetic Rats" Pharmaceuticals 15, no. 9: 1062.
https://doi.org/10.3390/ph15091062
APA Style
MartÃnez-López, A. L., Carvajal-Millan, E., Canett-Romero, R., Prakash, S., Rascón-Chu, A., López-Franco, Y. L., Lizardi-Mendoza, J., & Micard, V.
(2022). Arabinoxylans-Based Oral Insulin Delivery System Targeting the Colon: Simulation in a Human Intestinal Microbial Ecosystem and Evaluation in Diabetic Rats. Pharmaceuticals, 15(9), 1062.
https://doi.org/10.3390/ph15091062